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Abstract
Background: Left ventricular hypertrophy (LVH) is one of the risk factors for cardiovascular (CV) disease and mortality.
However, the relationship between socioeconomic status (SES) and LVH in chronic kidney disease remains unclear.
Methods: Data were collected from the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease
(KNOW-CKD, NCT01630486 at http://www.clinicaltrials.gov). Subjects with CKD and aged ≥50 were included. SES was
characterized based on monthly income and educational attainment, each of which was divided into three strata. LVH
was defined as LV mass/height2.7≥ 47 g/m2.7 in female and≥ 50 g/m2.7 in male. Age, sex, diabetes, CKD stage, body
mass index, blood pressure and physical activity were included as covariates.
Results: A total of 1361 patients were included. Mean age was 60.9 ± 6.9 years, and 63.2% were men. Higher education
level was associated with higher monthly income (P for trend < 0.001). The lowest education level was independently
associated with LVH (lower than high school, adjusted odds ratio [OR] 1.485, 95% CI 1.069–2.063, P = 0.018; completed
high school, adjusted OR 1.150, 95% confidence interval [CI] 0.834–1.584, P = 0.394; highest education level as the
reference). Monthly income level was marginally associated with LVH after adjusting for covariates ($1500-4500, adjusted
OR 1.230, 95% CI 0.866–1.748, P = 0.247; < $1500, adjusted OR 1.471, 95% CI 1.002–2.158, P = 0.049; > $4500; reference).
Conclusions: In the CKD population, lower SES, defined by educational attainment and low income level exhibited a
significant association with LVH, respectively. Longitudinal follow-up will reveal whether lower SES is associated with poor
CKD outcomes.
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Backgrounds
Socioeconomic status (SES) is an important and strong pre-
dictor of morbidity and mortality. [1] Generally, education
level, occupation, race, housing, social support and income
are key components to be evaluated as SES. Multiple deter-
minants of health care level vary with SES levels, including
risk of all-cause mortality, [2] cardiovascular diseases, [3–5]
diabetes mellitus, [5, 6] cancer, [7, 8] and chronic kidney
disease (CKD) [5, 9]. The reasons behind this phenomenon
have been suggested as follows: educational attainment and
income levels contribute to a complex set of
socio-economic determinants, including insurance, trans-
portation, stress, housing quality and access to health care
[10]. Such determinants may interact and combine to affect
the health outcomes in an interconnected mechanism. Be-
cause SES appears to affect CKD patients in a similar way
as it does the general population, it is important to clarify
the health-related risk factors in CKD influenced by SES.
Worldwide, cardiovascular diseases are the leading
cause of death among patients with CKD and end-stage
renal disease (ESRD). Cardiovascular mortality is the pri-
mary cause of death in CKD patients in Korea, account-
ing for the 39% of mortality cases in peritoneal dialysis
and 36% in hemodialysis patients [11]. Thus, most physi-
cians make every effort to prevent a cardiovascular event
and control its risk factors, such as lipid levels and
anemia. Above all, left ventricular hypertrophy (LVH)
causes decreased diastolic compliance and leads to is-
chemic cardiomyopathy, even in the absence of coronary
artery disease [12]. More specifically, in a cohort of pa-
tients starting dialysis therapy, cardiac enlargement and
decreased systolic function exhibited a relationship with
ischemic heart disease and cardiac failure [13].
Meanwhile, in a previous study, Carlos et al. [14] re-
ported that lower SES is an independent risk factor for
increased left ventricular mass among hypertensive and
normotensive African Americans. However, the relation-
ship between SES and risk factors of cardiovascular mor-
tality, including left ventricular hypertrophy (LVH), are
less well known among CKD patients.
Since some social determinants of health are modifiable
through education and governmental health policies, in-
vestigating the influence of SES on the outcome of CKD is
crucial. Therefore, we investigated the association between
LVH, the representative risk factor for CV mortality in
CKD and socioeconomic status, evaluated by educational
attainment and monthly income level, among participants
in the KoreaN cohort study for Outcome in patients With
Chronic Kidney Disease (KNOW-CKD).
Methods
Study population
Participants in the KNOW-CKD, a Korean multicenter
prospective cohort study that enrolled subjects with CKD
from stage 1 to 5 (predialysis) from June 30, 2011 to Janu-
ary 29, 2016, were included in this cross-sectional analysis.
The detailed design and methods of the KNOW-CKD have
been previously published elsewhere [15]. In total, 2238
participants were enrolled in the KNOW-CKD study.
Among them, we excluded individuals who did not respond
to the questionnaire regarding SES, no measured left ven-
tricular (LV) mass, and who were aged < 50 years (Fig. 1).
Finally, 1330 subjects were included in the analyses.
Variable measurements
Demographics, and clinical and laboratory values at enroll-
ment were extracted from an electronic data management
system (http://www.phactaX.org). The estimated glomeru-
lar filtration rate (eGFR) was estimated using the Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI)
equation using creatinine [16]. Resting blood pressure was
measured with mercury sphygmomanometers and cuffs of
appropriate size three times for average blood pressure.
Hypertension (HTN) was defined as a blood pressure re-
cording ≥140/90 mmHg, a self-reported history of hyper-
tension, or use of antihypertensive agents. Diabetes (DM)
was defined by self-reporting or use of hypoglycemic medi-
cations. Physical activity was quantified by the International
Physical Activity Questionnaire. Subjects were categorized
by total Metabolic Equivalent of Task (MET) - minutes/
week; “high” was defined as ≥3000 METs-minutes/week,
“moderate” as 600–2999 METs-minutes/week and “low” as
< 600 METs-minutes/week. Anemia was defined as
hemoglobin < 13 g/dL for males, or < 12 g/dL for females.
Two-dimensional echocardiography was conducted to
measure cardiac parameters. LV mass was calculated by 0.8
x {1.04[(LVIDd + PWTd + SWTd)3 - (LVIDd)3]} + 0.6 g,
where PWTd and SWTd are posterior wall thickness at
end diastole and septal wall thickness at end diastole, re-
spectively [17]. Left ventricular hypertrophy (LVH) was de-
fined as LV mass/height2.7 ≥ 47 g/m2.7 in female and ≥ 50 g/
m2.7 in male, [17, 18] because LV mass indexed to body sur-
face area is problematic in that weight is affected by volume
overload in CKD [19].
Fig. 1 Study Flow. Abbreviations: SES, socioeconomic status; LV,
left ventricular
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Evaluation of socioeconomic status
The questionnaire used in the KNOW-CKD Study followed
those of the Korea National Health and Nutrition Examin-
ation Survey (KNHANES). The KNAHES classified the
monthly income of Korean population into three intervals,
based on the average household income of the contempor-
ary Koreans. Information on educational attainment and
monthly income level, which were captured from
patient-reported questionnaire, was used as indicators of
SES. With regard to educational attainment, the patients
were asked about the level at which their formal school
education was completed. Educational attainment was clas-
sified into three levels: “less than high school” included
those who never went to high school or who completed
only part of high school, “completed high school” included
those who had graduated high school but not completed
college, “college degree or beyond” included those who had
completed college or a higher degree. Monthly income level
was classified into three levels: less than $ 1500, $ 1500 to $
4500, and over $ 4500 per month.
Statistical analysis
Continuous variables are presented as a mean ± standard
deviation. Proportions were used for categorical vari-
ables, including age groups, sex, CKD stages, comorbidi-
ties (e.g., diabetes mellitus). We used one-way analysis of
variance for comparison of continuous variables and the
χ2 test for categorical variables. Statistical significance
was determined at P < 0.05 using two-sided tests. We
conducted logistic regression to evaluate the association
between LVH and SES, which is categorized into three
education or monthly income levels. We checked the
Hosmer-Lemeshow goodness of fit test for determining
whether multivariable models are fit of data. Statistical
analyses were carried out using the SPSS software pack-
age, version 22.0 (IBM Corporation, Armonk, NY, USA).
Ethics statement
The study protocol was approved by the Institutional Re-
view Board at each participating clinical center — i.e., Seoul
National University Hospital (1104–089-359), Seoul Na-
tional University Bundang Hospital (B-1106/129–008), Yon-
sei University Severance Hospital (4–2011-0163), Kangbuk
Samsung Medical Center (2011–01-076), Seoul St. Mary’s
Hospital (KC11OIMI0441), Gil Hospital (GIRBA2553), Eulji
General Hospital (201105–01), Chonnam National Univer-
sity Hospital (CNUH-2011-092), and Pusan Paik Hospital
(11–091) in 2011. This study was conducted in accordance
with the principles of the Declaration of Helsinki.
Results
Baseline characteristics of study participants
The baseline characteristics of the study subjects are
shown in Table 1. Mean age was 60.9 ± 6.9 years, and 860
(63.2%) were men. Mean eGFR was 45.5 ± 25.1 mL/min/
1.73 m2 and the number of patients with a CKD stage
G3a, G3b, G4, and G5 were 226 (16.6%), 250 (18.4%), 322
(23.7%), 352 (25.9%) and 1023 (75.1%), respectively. Dia-
betic nephropathy was the most common cause of CKD
(31.8%), followed by glomerulonephritis (25.3%), hyperten-
sive nephropathy (24.2%), and polycystic kidney disease
(10.4%). Subjects with DM and HTN comprised 42.0%
and 98.0% of the study participants, respectively. Anemia
was prevalent in 662 (49.1%) subjects and 119 (8.7%) sub-
jects received erythropoiesis-stimulating agents (ESAs).
Comparison of baseline characteristics according to
socioeconomic status
We compared baseline characteristics according to edu-
cational attainment (Table 1) and monthly income levels
(Table 2). With respect to educational attainment strata,
the mean age was 2 years older in the lowest educational
group. Subjects in the lowest education group exhibited
the lowest eGFR (47.1 ± 23.3 for ‘college or beyond,’ 46.7
± 26.6 for ‘completed high school,’ and 42.7 ± 25.0 mL/
min/1.73 m2 for ‘less than high school’ groups, respect-
ively; P for trend = 0.008). The higher education group
was associated with higher monthly family income (P for
trend < 0.001). The prevalence of anemia increased with
decreasing level of educational attainment (41.2%, 48.8%,
and 57.0%, respectively; P for trend < 0.001). The lowest
educational attainment was an independent risk factor
for anemia, even after adjusting for age, sex, and eGFR
(‘less than high school’, OR 1.515, 95% CI 1.075–2.136,
P = 0.018). The proportion of diabetic patients was the
highest in the lowest education group. No group differ-
ences were exhibited in sodium excretion from 24-h
urine collection.
When the subjects were categorized based on monthly
income level, similar trends were observed in terms of age,
eGFR, DM, anemia and 24-h sodium excretion (Table 2).
Socioeconomic status and left ventricular hypertrophy
The total number of patients diagnosed with LVH on
echocardiography was 413 (30.3%). With the increase of
the household income level or with the increase of the
educational level, the prevalence of LVH gradually in-
creased (Tables 1 and 2, P for trend < 0.001, respect-
ively). In unadjusted analyses, risk of LVH increased
with decreasing levels of educational attainment and
monthly income level, respectively (Table 3, Table 4, and
Fig. 2). In particular, the lowest educational level (lower
than high school) was independently associated with
LVH after adjusting for age, sex, body mass index, mean
arterial pressure, DM, CKD stage and physical activity
(‘college or beyond,’ reference; ‘completed high school’,
OR 1.150, 95% CI 0.834–1.584; ‘less than high school’
OR 1.485, 95% CI 1.069–2.063; Fig. 3). Additionally,
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Table 1 Baseline Characteristics according to Educational attainment







1361 437 467 457
Age (year, mean ± SD) 60.9 ± 6.9 60.3 ± 7.1 60.0 ± 6.9 62.4 ± 6.6 < 0.001 < 0.001
Male (N, %) 860 (63.2) 361 (82.6) 299 (64.0) 200 (43.8) < 0.001 < 0.001
LVH (N, %) 413 (30.3) 101 (23.1) 132 (28.3) 180 (39.4) < 0.001 < 0.001
eGFR (mL/min/1.73m2) 45.5 ± 25.1 47.1 ± 23.3 46.7 ± 26.6 42.7 ± 25.0 0.001a 0.008
BMI (kg/m2, mean ± SD) 24.6 ± 3.1 24.6 ± 2.9 24.4 ± 3.2 24.9 ± 3.2 0.049 0.155
CKD stage (N, %) < 0.001 < 0.001
Stage G1 112 (8.2) 27 (6.2) 50 (10.7) 35 (7.7)
Stage G2 226 (16.6) 89 (20.3) 72 (15.4) 65 (14.2)
Stage G3a 250 (18.4) 107 (24.5) 83 (17.8) 60 (13.1)
Stage G3b 322 (23.7) 90 (20.6) 112 (24.0) 120 (26.3)
Stage G4 352 (25.9) 101 (23.1) 114 (24.4) 137 (30.0)
Stage G5 99 (7.3) 23 (5.3) 36 (7.7) 40 (8.8)
Underlying renal disease (N, %) 0.042 0.049
Diabetic nephropathy 429 (31.8) 130 (29.9) 142 (30.7) 157 (34.7)
Hypertensive nephropathy 327 (24.2) 109 (25.1) 105 (22.7) 113 (25.0)
Glomerulonephritis 341 (25.3) 104 (23.9) 136 (29.4) 101 (22.3)
Polycystic kidney disease 140 (10.4) 60 (13.8) 42 (9.1) 38 (8.4)
Diabetes mellitus (N, %) 571 (42.0) 168 (38.4) 189 (40.5) 214 (46.8) 0.022 0.019
bHemoglobin A1c (%, mean ± SD) 6.9 ± 1.4 6.7 ± 1.2 6.9 ± 1.3 7.1 ± 1.5 0.005a 0.001
Hypertension (N, %) 1334 (98.0) 430 (98.4) 457 (97.9) 447 (97.8) 0.673 0.635
Systolic blood pressure (mmHg, mean ± SD) 128.84 ± 16.7 127.8 ± 15.2 129.1 ± 17.3 129.5 ± 17.5 0.539a 0.138
Diastolic blood pressure (mmHg, mean ± SD) 75.9 ± 11.2 76.3 ± 10.7 76.6 ± 10.9 74.9 ± 11.8 0.071 0.068
Monthly income (N, %) < 0.001 < 0.001
> $ 4500 269 (19.8) 163 (37.3) 73 (15.6) 33 (7.2)
$ 1500 to 4500 701 (51.5) 214 (49.0) 279 (59.7) 208 (45.5)
< $ 1500 391 (28.7) 60 (13.7) 115 (24.6) 216 (47.3)
Physical activity (N, %) < 0.001 < 0.001
High 287 (21.1) 95 (21.7) 112 (24.0) 80 (17.5)
Moderate 536 (39.4) 201 (46.0) 170 (36.4) 165 (36.1)
Low 538 (39.5) 141 (32.3) 185 (39.6) 212 (46.4)
Anemia (N, %) 662 (49.1) 178 (41.2) 225 (48.8) 259 (57.0) < 0.001 < 0.001
ESA (N, %) 119 (8.7) 30 (6.9) 33 (7.1) 56 (12.3) 0.005 0.006
Serum laboratory values
Hemoglobin (g/dL, mean ± SD) 12.6 ± 2.0 13.2 ± 2.0 12.6 ± 1.9 12.0 ± 1.92 < 0.001 < 0.001
Creatinine (mg/dL, mean ± SD) 1.9 ± 1.1 1.9 ± 1.1 1.9 ± 1.1 1.9 ± 1.1 0.986 0.869
Albumin (g/dL, mean ± SD) 4.2 ± 0.4 4.2 ± 0.4 4.2 ± 0.4 4.1 ± 0.4 0.014 0.003
Calcium (mg/dL, mean ± SD) 9.1 ± 0.5 9.1 ± 0.5 9.1 ± 0.5 9.1 ± 0.5 0.413 0.206
Phosphorus (mg/dL, mean ± SD) 3.7 ± 0.7 3.6 ± 0.6 3.7 ± 0.7 3.9 ± 0.7 < 0.001 < 0.001
Total cholesterol (mg/dL, mean ± SD) 170.7 ± 38.2 168.8 ± 36.8 170.6 ± 37.4 172.7 ± 40.1 0.309 0.126
LDL (mg/dL, mean ± SD) 93.1 ± 31.8 91.5 ± 30.9 93.2 ± 32.4 94.4 ± 31.9 0.396 0.176
cHDL (mg/dL, mean ± SD) 47.7 ± 14.6 47.4 ± 14.3 47.7 ± 13.6 48.9 ± 15.9 0.816 0.527
dTriglyceride (mg/dL, mean ± SD) 159.2 ± 95.7 157.0 ± 89.4 157.7 ± 85.7 162.8 ± 110.3 0.607 0.361
Kang et al. BMC Nephrology  (2018) 19:203 Page 4 of 11
when anemia included as a covariate in the
multi-variable model, the association between the lowest
education level and LVH still showed the statistical sig-
nificance (OR 1.454, 95% CI 1.042–2.028; P = 0.028,
Table 3). Monthly income level is a risk factor for LVH
in univariate and multivariate analysis adjusted age, sex,
body mass index, mean arterial pressure, diabetes, CKD
stages and physical activity. However, the inclusion of
anemia as a covariates in the multivariable analysis at-
tenuated the relationship between income level and
LVH, as shown in the Table 4 (> $ 4500, reference; $
1500 - 4500, OR 1.174, 95% CI 0.825–1.672, P = 0.373; <
$ 1500, OR 1.415, 95% CI 0.962–2.081, P = 0.078).
Discussion
We performed cross-sectional analysis for the relation-
ships between SES and LVH in a CKD population over
50 years of age. LVH was associated with parameters of
SES, such as educational attainment and monthly income
level, and these associations had graded responses. Add-
itional analyses were conducted to clarify the association
between SES and LVH, adjusting for body mass index,
sex, age, blood pressure, DM, CKD stages and physical ac-
tivity. After adjustment, lower education and income level
remained a statistically significant determinant of LVH.
Compared with the statistical data of the Organization
for Economic Co-operation and Development (OECD)
statistics, the proportions of college graduates or above
among the subjects at 25–45 years of age, were 69% for
Koreans and 42% for the average OECD countries, re-
spectively, while among those at 55–64 years of age, they
are 18% in Korea and 26% in OECD average [20, 21].
Namely, since most of the younger Korean population are
college graduates, educational attainment is not a suitable
factor for evaluating the SES among younger Korean CKD
patients. In such a respect, the present study included only
the subjects at the age of 50 or older.
Usually, SES is defined by education, employment, income
and poverty, and these indicators could influence one’s ac-
cess to medical care and social support through insurance,
housing stability and quality, accessibility to healthy food
and degree of stress [10]. Since numerous complex interac-
tions between the selected social determinants of health
exist, it is difficult to elucidate the mechanism for the asso-
ciation between SES and many clinical outcomes regarding
the incidence, progression of disease and mortality. In par-
ticular, low educational attainment has indirect effects on
one’s understanding of disease and medical treatment. Low
income level could affect one’s ability to engage in healthy
behavior and access to healthcare services. It is important to
identify clinical outcomes influenced by SES, because some
determinants could be modified by government policies, so-
cial support for access medical care, and efforts of physi-
cians and community members.
Explanations for the differences in the burden of LVH be-
tween various strata of socio-economic status remain
speculative, but there are several potential reasons why
lower SES could be an independent risk factor for LVH.
First, socioeconomically disadvantaged patients tend to re-
ceive less vigorous treatment because of poorer access to
medical care [22]. It is well known that early referral to a
nephrologist improves clinical outcomes in CKD patients
[23, 24] due to timely and proper management for preven-
tion of disease progression. The primary system of South
Korea health insurance system is the National Health Insur-
ance (NHI), and nearly 96% of the total Korean population
joined this NHI program [25]. It guarantees the basic med-
ical cares including in-patient and out-patient health ser-
vice, preventive care and prescription drugs, based on the
co-payment system [26]. However, with the rapid expansion
of enrolled population, the NHI has been under the heavy
burdens due to increased medical expenditure [27]. Inevit-
ably, the NHI program had to restrict the range of covered
medical services at the possible level [28]. Therefore, some
medical services or medical tests at high costs are not
Table 1 Baseline Characteristics according to Educational attainment (Continued)







1361 437 467 457
e25-OH vitamin D (ng/mL, mean ± SD) 18.5 ± 8.5 19.1 ± 9.0 18.5 ± 7.3 17.9 ± 9.2 0.126 0.042
f24 hour urine sodium
(mmol/day, mean ± SD)
154.8 ± 67.7 156.4 ± 64.7 155.5 ± 70.2 152.7 ± 67.9 0.44 0.437
Abbreviations: SD standard deviation, eGFR estimated glomerular filtration rate, BMI body mass index, CKD chronic kidney disease, ESA erythropoiesis-stimulating
agent, LDL low density lipoprotein, HDL high density lipoprotein
aKruskal-Wallis test was used to evaluate P value
bHemoglobin A1c was measured only in the diabetic patients. (Total 724 patients; college or beyond group, 205 patients; completed high school 242 patients;
lower than high school 277 patients)
cHDL was measured in 1342 patients (missing value = 19)
dTriglyceride was measured in 1329 patients (missing value = 32)
e25-OH vitamin D was measured in 1331 patients (missing value = 30)
f24 hour urine sodium was measured in 1240 patients (missing value = 121)
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Table 2 Baseline Characteristics according to Monthly Income Level
N Total Monthly income P P for
trend> $ 4500 $1500 to $4500 < $ 1500
1361 269 701 391
Age (year, mean ± SD) 60.9 ± 6.9 59.0 ± 6.6 60.6 ± 6.9 62.8 ± 6.7 < 0.001 < 0.001
Male (N, %) 860 (63.2) 199 (74.0) 433 (61.8) 228 (58.3) < 0.001 < 0.001
LVH (N, %) 413 (30.3) 60 (22.3) 205 (29.2) 148 (37.9) < 0.001 < 0.001
eGFR (mL/min/1.73m2) 45.5 ± 25.1 49.9 ± 24.9 46.5 ± 25.2 40.5 ± 24.3 < 0.001 < 0.001
BMI (kg/m2, mean ± SD) 24.6 ± 3.1 24.6 ± 2.8 24.6 ± 3.2 24.7 ± 3.2 0.586 0.403
CKD stage (N, %) < 0.001 < 0.001
Stage G1 112 (8.2) 27 (10.0) 60 (8.6) 25 (6.4)
Stage G2 226 (16.6) 58 (21.6) 115 (16.4) 53 (13.6)
Stage G3a 250 (18.4) 54 (20.1) 145 (20.7) 51 (13.0)
Stage G3b 322 (23.7) 60 (22.3) 171 (24.4) 91 (23.3)
Stage G4 352 (25.9) 59 (21.9) 162 (23.1) 131 (33.5)
Stage G5 99 (7.3) 11 (4.1) 48 (6.8) 40 (10.2)
Underlying renal disease (N, %) < 0.001 < 0.001
Diabetic nephropathy 429 (31.8) 59 (22.0) 223 (32.2) 147 (27.8)
Hypertensive nephropathy 327 (24.2) 71 (25.4) 173 (25.0) 83 (21.3)
Glomerulonephritis 341 (25.3) 88 (32.8) 179 (25.8) 74 (19.0)
Polycystic kidney disease 140 (10.4) 39 (14.6) 63 (9.1) 38 (9.8)
Diabetes mellitus (N, %) 571 (42.0) 88 (32.7) 291 (41.5) 192 (49.1)
bHemoglobin A1c (%, mean ± SD) 6.9 ± 1.4 6.8 ± 1.2 6.9 ± 1.3 7.0 ± 1.5 0.293 0.125
Hypertension (N, %) 1334 (98.0) 268 (99.6) 688 (98.1) 378 (96.7) 0.069 0.041
Systolic blood pressure (mmHg) 128.84 ± 16.7 127.0 ± 14.1 128.3 ± 17.3 131.0 ± 17.1 0.005a 0.001
Diastolic blood pressure (mmHg) 75.9 ± 11.2 77.1 ± 10.2 75.6 ± 11.3 75.8 ± 11.5 0.175 0.224
Educational attainment (N, %) < 0.001 < 0.001
College graduate or higher 437 (32.1) 163 (60.6) 214 (30.5) 60 (15.3)
Completed high school 467 (34.3) 73 (27.1) 279 (39.8) 115 (29.4)
Lower than high school 347 (33.6) 33 (12.3) 208 (29.7) 216 (55.2)
Physical activity (N, %) < 0.001 < 0.001
High 287 (21.1) 55 (20.4) 156 (22.3) 76 (19.4)
Moderate 536 (39.4) 137 (50.9) 259 (36.9) 140 (35.8)
Low 538 (39.5) 77 (28.6) 286 (40.8) 175 (44.8)
Anemia (N, %) 662 (49.1) 101 (37.8) 345 (49.8) 216 (55.8) < 0.001 < 0.001
ESA (N, %) 119 (8.7) 12 (4.5) 71 (10.1) 36 (9.2) 0.019 0.01
Serum laboratory values
Hemoglobin (g/dL) 12.6 ± 2.0 13.2 ± 1.9 12.6 ± 2.0 12.2 ± 1.9 < 0.001 < 0.001
Creatinine (mg/dL) 1.9 ± 1.1 1.8 ± 1.0 1.9 ± 1.1 2.1 ± 1.2 < 0.001a < 0.001
Albumin (g/dL) 4.2 ± 0.4 4.2 ± 0.3 4.1 ± 0.4 4.1 ± 0.4 0.003a 0.001
Calcium (mg/dL) 9.1 ± 0.5 9.2 ± 0.5 9.1 ± 0.5 9.1 ± 0.5 0.012 0.004
Phosphorus (mg/dL) 3.7 ± 0.7 3.6 ± 0.5 3.7 ± 0.7 3.8 ± 0.7 0.003a 0.001
Total cholesterol (mg/dL) 170.7 ± 38.2 171.0 ± 37.0 171.4 ± 39.4 159.3 ± 36.8 0.692a 0.508
LDL (mg/dL) 93.1 ± 31.8 91.1 ± 32.4 94.4 ± 31.9 92.1 ± 31.1 0.281 0.851
cHDL (mg/dL) 47.7 ± 14.6 49.7 ± 14.5 47.4 ± 14.2 46.9 ± 14.3 0.051 0.029
dTriglyceride (mg/dL) 159.2 ± 95.7 143.7 ± 101.3 160.6 ± 100.0 159.6 ± 83.4 0.692 0.585
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covered by the NHI, rendering them not easily accessible to
the individuals at low SES. In addition, low SES leads to de-
creased understanding of treatment plans and poor compli-
ance, which result in late diagnosis and disease progression.
Second, sympathetic stimulation is one of the mecha-
nisms of LVH in low SES. The role of stress in health
has been investigated since the 1950s [29] and the asso-
ciation between stress and cardiovascular disease is well
known [30–33]. Sympathetic nervous system activity in-
creases with various environmental factors, including
low SES and stress. Lower SES is an important factor in
psychosocial stress relative to higher SES [34]. It has
Table 2 Baseline Characteristics according to Monthly Income Level (Continued)
N Total Monthly income P P for
trend> $ 4500 $1500 to $4500 < $ 1500
1361 269 701 391
e25-OH vitamin D (ng/mL) 18.5 ± 8.5 19.4 ± 8.2 18.7 ± 9.0 17.6 ± 7.9 0.019 0.006
f24 hour urine sodium (mmol/day) 154.8 ± 67.7 157.4 ± 67.5 152.1 ± 66.5 157.8 ± 69.6 0.348 0.797
Abbreviations: SD standard deviation, eGFR estimated glomerular filtration rate, BMI body mass index, CKD chronic kidney disease, ESA erythropoiesis-stimulating
agent, LDL low density lipoprotein, HDL high density lipoprotein
aKruskal-Wallis test was used to evaluate P value
bHemoglobin A1c was measured only in the diabetic patients. (Total 724 patients; >$4500, 115 patients; $1500 to $4500, 152 patients; <$1500, 252 patients)
cHDL was measured in 1342 patients (missing value = 19)
dTriglyceride was measured in 1329 patients (missing value = 32)
e25-OH vitamin D was measured in 1331 patients (missing value = 30)
f24 hour urine sodium was measured in 1240 patients (missing value = 121)
Table 3 The relationship between LVH and educational attainment
Univariate analysis Multivariate (model 1) Multivariate (model 2)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Age
50–59 reference reference reference
60–69 1.575 (1.218–2.036) 0.001 1.409 (1.068–1.859) 0.015 1.442 (1.090–1.908) 0.01
≥ 70 2.468 (1.764–3.453) < 0.001 2.246 (1.553–3.248) < 0.001 2.308 (1.593–3.342) < 0.001
Sex (vs. men) 1.797 (1.419–2.275) < 0.001 1.863 (1.413–2.456) < 0.001 1.885 (1.426–2.491) < 0.001
BMI (reference ≤ 23.0) 2.254 (1.707–2.976) < 0.001 2.401 (1.786–3.277) < 0.001 2.457 (1.820–3.315) < 0.001
MAP 1.018 (1.010–1.027) < 0.001 1.018 (1.008–1.027) < 0.001 1.019 (1.009–1.028) < 0.001
DM 1.598 (1.266–2.017) < 0.001 1.208 (0.934–1.563) 0.151 1.159 (0.890–1.510) 0.275
CKD stage
1 reference reference reference
2 1.409 (0.794–2.500) 0.241 1.464 (0.808–2.652) 0.209 1.365 (0.748–2.490) 0.311
3a 1.297 (0.735–2.291) 0.369 1.293 (0.713–2.343) 0.398 1.216 (0.666–2.223) 0.524
3b 1.983 (1.157–3.400) 0.013 1.776 (1.011–3.121) 0.046 1.613 (0.905–2.875) 0.105
4 3.185 (1.878–5.401) < 0.001 3.007 (1.723–5.248) < 0.001 2.609 (1.443–4.715) 0.002
5 3.680 (1.969–6.877) < 0.001 3.146 (1.630–6.071) 0.001 2.645 (1.311–5.337) 0.007
Physical activity
Low 0.942 (0.688–1.290) 0.711 0.786 (0.560–1.101) 0.161 0.817 (0.580–1.149) 0.245
Moderate 1.108 (0.812–1.511) 0.518 0.747 (0.532–1.049) 0.093 0.764 (0.541–1.078) 0.125
High reference reference reference
Anemia 1.790 (1.414–2.266) < 0.001 1.219 (0.904–1.645) 0.194
Educational attainment
College graduate or more reference reference reference
Completed high school 1.311 (0.971–1.770) 0.077 1.150 (0.834–1.584) 0.394 1.141 (0.825–1.579) 0.425
lower than high school 2.162 (1.616–2.892) < 0.001 1.485 (1.069–2.063) 0.018 1.454 (1.042–2.028) 0.028
Abbreviations: CI confidential interval, vs., versus, BMI body mass index, MAP mean arterial pressure, DM diabetes mellitus, CKD Chronic kidney disease;
Model 1: age, sex, BMI, MAP, DM, CKD stage, physical activity, educational attainment, P for trend according to education attainment = 0.017, P for Hosmer and
Lemeshow goodness of fit test = 0.090
Model 2: age, sex, BMI, MAP, DM, CKD stage, physical activity, anemia, educational attainment, P for trend according to education attainment = 0.025, P for
Hosmer and Lemeshow goodness of fit test = 0.086
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been reported that chronic adrenergic stimulation can
cause increased left ventricular mass [35]. Moreover, pa-
tients with CKD may be unable to adapt easily to stress-
ful situations because stress hormones are metabolized
and cleared by the kidney [36]. Patients with CKD may
present inappropriate reactions to chronic stress. Thus,
CKD patients with lower SES might be subjected both to
more stress, and inappropriate responses to the stress.
Dietary differences between low and high SES groups
are also related to LVH. One study reported that in-
creased sodium retention might increase the risk of LVH
by activation of the renin-angiotensin system and
Table 4 The relationship between LVH and household income level
Univariate analysis Multivariate (model 3) Multivariate (model 4)
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Age
50–59 reference reference reference
60–69 1.575 (1.218–2.036) 0.001 1.409 (1.067–1.861) 0.016 1.444 (1.091–1.913) 0.01
≥ 70 2.468 (1.764–3.453) < 0.001 2.255 (1.561–3.260) < 0.001 2.318 (1.601–3.356) < 0.001
Sex (vs. men) 1.797 (1.419–2.275) < 0.001 2.027 (1.559–2.635) < 0.001 2.044 (1.569–2.664) < 0.001
BMI (reference ≤ 23.0) 2.254 (1.707–2.976) < 0.001 2.438 (1.813–3.278) < 0.001 2.496 (1.849–3.369) < 0.001
MAP 1.018 (1.010–1.027) < 0.001 1.017 (1.008–1.027) < 0.001 1.018 (1.009–1.028) < 0.001
DM 1.598 (1.266–2.017) < 0.001 1.212 (0.837–1.568) 0.143 1.159 (0.890–1.510) 0.275
CKD stage
1 reference reference reference
2 1.409 (0.794–2.500) 0.241 1.443 (0.798–2.611) 0.225 1.346 (0.739–2.451) 0.332
3a 1.297 (0.735–2.291) 0.369 1.254 (0.693–2.270) 0.454 1.178 (0.646–2.148) 0.592
3b 1.983 (1.157–3.400) 0.013 1.770 (1.008–3.108) 0.047 1.599 (0.898–2.847) 0.111
4 3.185 (1.878–5.401) < 0.001 2.945 (1.689–5.136) < 0.001 2.527 (1.399–4.565) 0.002
5 3.680 (1.969–6.877) < 0.001 3.034 (1.572–5.856) 0.001 2.525 (1.252–5.091) 0.01
Physical activity
Low 0.942 (0.688–1.290) 0.711 0.791 (0.565–1.109) 0.174 0.819 (0.582–1.152) 0.251
Moderate 1.108 (0.812–1.511) 0.518 0.747 (0.532–1.409) 0.092 0.762 (0.540–1.076) 0.122
High reference reference reference
Anemia 1.790 (1.414–2.266) < 0.001 1.240 (0.920–1.672) 0.158
Income level
> $ 4500 reference reference reference
$ 1500-4500 1.440 (1.035–2.003) 0.03 1.230 (0.866–1.748) 0.247 1.174 (0.825–1.672) 0.373
< $ 1500 2.122 (1.491–3.018) < 0.001 1.471 (1.002–2.158) 0.049 1.415 (0.962–2.081) 0.078
Abbreviations: CI confidential interval, vs., versus, BMI body mass index, MAP mean arterial pressure, DM diabetes mellitus, CKD Chronic kidney disease;
Model 3: age, sex, BMI, MAP, DM, CKD stage, physical activity, income level, P for trend according to income level = 0.045, P for Hosmer and Lemeshow goodness
of fit test = 0.381
Model 4: age, sex, BMI, MAP, DM, CKD stage, physical activity, anemia, income level, P for trend according to income level = 0.06, P for Hosmer and Lemeshow
goodness of fit test = 0.111
Fig. 2 Odds Ratio for LVH according to SES in Univariate Analysis. Abbreviations: LVH, left ventricular hypertrophy; SES, socioeconomic status;
USD, US dollar. *: P < 0.005
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volume expansion [37]. Sodium intake tended to be
higher among individuals with low SES [38–40]. In a
study carried out among Chinese individuals, more edu-
cated participants had a lower intake of salt and soy
sauce compared with less educated individuals [41]. This
tendency might also be present in CKD populations, and
dietary differences could contribute to a greater risk of
LVH by sodium intake differences. Although this study
did not collect dietary information, we attempted to
evaluate sodium intake by measuring 24-h urine Na ex-
cretion, as it might reflect dietary sodium intake [42,
43]. However, our data did not show a significant differ-
ence in 24-h urine Na excretion with respect to educa-
tional attainment or income level. Since the main source
of sodium intake in the western countries is processed
foods (77% in the United States and 65–70% in the
United Kingdom), people with low SES are less likely to
have access to fresh food, thus, they are more likely to
consume more processed food. In other words, the more
processed food consumed, the more sodium intake.
However, in South Korea, the main sources of salt intake
are Kimchi, soup and stew, and these are easily access-
ible to anyone regardless of SES. Therefore, in Korea,
personal salt intake depends more heavily on the per-
sonal salt preference, rather than on the SES of the indi-
vidual. In addition, though adults should consume less
than 2000 mg of sodium, or 5 g of salt per day according
to guidelines issued by the World Health Organization
(WHO) [44], Korean sodium intake is very high, because
Korean food is generally very salty. In fact, looking at
KNHANES data, the amount of sodium intake in Korea
is 3669 mg, far exceeding 2000 mg [45].
Anemia has been shown to be an independent risk fac-
tor for LVH in CKD patients [46, 47]. The relationship
between SES and anemia has been assessed primarily
among adolescents and reproductive-aged women, for
whom low SES is an important risk factor for anemia
[48, 49]. Low iron intake among low SES populations
also has been well established [50, 51]. In our subjects,
anemia was more prevalent in the lowest educational
group. Based on the above findings, we hypothesized
that low SES might be associated with anemia, which, in
turn, might lead to LVH. Our study showed that inclu-
sion of anemia as a covariate in the multivariate analysis
attenuated the significant association between low in-
come and LVH. This means that anemia could partly be
a contributing factor to the development of LVH in the
CKD subjects in lower SES. However, even after adjust-
ment for anemia as a covariate, low educational attain-
ment still remained an independent risk factor for LVH
(lower than high school, OR 1.454, 95% CI 1.042–2.028,
P = 0.028; Table 3). Namely, other social determinants
affected by SES but not included in the analysis might
contribute to LVH. Further studies are warranted for
elucidating the interconnected mechanism underlying
the association between SES and LVH.
Our study tried to evaluate the economic status more ac-
curately by surveying the individual or household monthly
income, rather than an area income. However, relative to
the association between education level and LVH, the asso-
ciation between monthly income level and LVH was some-
what attenuated after adjustment for anemia. It could be
speculated that regular monthly income does not represent
the overall economic status of a subject, particularly for an
elderly or retired person with ample savings or real estate,
but no regular monthly income. Therefore, a better param-
eter that could assess the economic status of an individual
subject needs to be investigated.
This study is the first, to our knowledge, to elucidate
that lower SES is an independent risk factor of LVH
among CKD population. However, several limitations
exist. First, although LVH is influenced by many factors,
and we tried to adjust as many factors as possible related
with health and dietary behavior, there still remains a
possibility for a residual confounder. Since this study
was conducted as a cross-sectional analysis, we could
not determine causality between SES and LVH. However,
longitudinal follow-up of the same study subjects will
show us the causal relationship between SES and CV
outcome. Second, we have excluded those who did not
Fig. 3 Odds Ratio for LVH according to SES in Multivariate Analysis. Adjusted for age, sex, mean arterial pressure, diabetes, CKD stage, physical
activity Abbreviations: LVH, left ventricular hypertrophy; SES, socioeconomic status; CKD, chronic kidney disease; USD, US dollar. *: P < 0.005
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respond to the self-questionnaire and LV mass measure-
ment. Because these patients are more likely to have
poor compliance, it might influence the results. In
addition, because information on the income and educa-
tional status was based only on the self-report, there
may be a reporting bias. Although echocardiography was
performed at each of nine participating centers, the data
coordinating center of the KNOW-CKD Study collected
each measurement parameter, calculated LV mass index,
and relative wall thickness and classified LV geometry
following a uniform criteria from the American Society
of Echocardiography [17]. Lastly, the study enrolled only
ethnic Korean patients; thus, it cannot provide informa-
tion on the ethnic disparities in CKD.
Conclusions
In summary, we identified a novel relationship between
SES and LVH in CKD patients. Lower SES, defined by
educational attainment and monthly income level, is an
independent factor for LVH among CKD patients. Further
studies are needed to explore the causal relationships be-
tween the SES and adverse cardiovascular outcomes in
the CKD population, to address factors related to
socio-environmental causes of LVH and to develop pre-
ventive strategies for CV mortality in patients with kidney
disease. Such efforts will minimize socio-economic dispar-
ities, and improve CV outcomes for patients with CKD.
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